Studies have shown that excess insulin circulating in the bloodstream is a major independent risk factor for cardiovascular disease. However, a new study from Joslin Diabetes Center finds that this condition, called hyperinsulinemia, itself does not cause hardening of the arteries, also known as atherosclerosis...
Men with type 2 diabetes who are treated with insulin are at higher risk risk for major cardiovascular events (e.g., death, heart attack, stroke) according to a new study conducted by researchers at Brigham and Women's Hospital (BWH). The researchers found that men with type 2 diabetes treated...
American Diabetes Association Alert Day® is a one-day "wake-up call” asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing type 2 diabetes. Held on the fourth Tuesday of every March, the next Alert Day will be held on March 27, 2012.
For every Diabetes Risk Test taken, Boar’s Head® - manufacturer of premium delicatessen products - will donate $5 to the American Diabetes Association starting March 27 through April 27, 2012, up to $50,000.
The European Commission has granted marketing authorization to Byetta (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents...
JDRF-funded scientists from the Indiana University School of Medicine have found that a specific type of cellular stress takes place in pancreatic beta cells before the onset of type 1 diabetes and this stress response in the beta cell may in fact help ignite the autoimmune attack....
A new study evaluating the efficacy and safety of adding dapagliflozin therapy to the treatment of type 2 diabetes patients whose blood glucose levels remain poorly controlled despite high doses of insulin was published today in the Annuls of Internal Medicine...
The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United States, marking a critical development in the effort by JDRF and its allies to bring this innovative and lifesaving diabetes technology to people with type 1 diabetes...
Although I live in an apartment with cat and dog hair scattered around and all the dirt that three little boys bring home, I'm a clean-freak at heart. I clean the keyboard on my laptop, I've been known to wipe down my cell phone, and recently I've thought quite a bit about the fact that Mike's insulin pump, which he's had for about nine months, is long overdue for a wash down...
The presence of gastric H. pylori bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c) and type 2 diabetes, according to a study in the Journal of Infectious Diseases. Yu Chen, PhD, and Martin Blaser, MD, at NYU School of Medicine, part of NYU Langone Medical Center...
Medtronic, Inc. today announced the international market launch of CareLink® Pro 3 Therapy Management Software, the first software program to offer advanced decision support to healthcare professionals managing diabetes. The software analyzes data from a patient’s insulin pump, continuous glucose monitoring...